Status:

ENROLLING_BY_INVITATION

Preimplantation Genetic Testing for Aneuploidy (PGT-A) in Couples With Non-obstructive Azoospermia (NOA)

Lead Sponsor:

Inception Fertility Research Institute, LLC

Conditions:

Non-obstructive Azoospermia

Male Infertility

Eligibility:

All Genders

Brief Summary

Objective: To examine the rate of embryo aneuploidy in patients with non-obstructive azoospermia (NOA) who utilize in-vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) and compare live...

Detailed Description

Preimplantation genetic testing for aneuploidy (PGT-A) facilitates selection of euploid embryos for transfer and may improve outcomes in select couples when the female partner is 35 or older. While em...

Eligibility Criteria

Inclusion

  • Couples who have undergone in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) with or without pre-implantation genetic testing for aneuploidy (PGT-A) at a fertility clinic in The Prelude Network (US sites only).
  • Male partner has diagnosis of non-obstructive azoospermia or obstructive azoospermia.
  • Male partner has undergone surgical sperm extraction.

Exclusion

  • not applicable

Key Trial Info

Start Date :

August 19 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2026

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT06566599

Start Date

August 19 2024

End Date

April 1 2026

Last Update

July 20 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Inception Fertility Research Institute

Houston, Texas, United States, 77081